Deadline for claims in July 9, 2009! The Wall Street Journal today reported on the three settlements resulting from PAL member lawsuits against drug wholesaler McKesson Corporation, and publishers First DataBank and MediSpan. (See article here.) One of t

The drug and medical device industry sent military pharmacists on more than 400 trips at a cost of more than $400,000 between 1998 and 2007, according to a new report from the Center for Public Integrity and Northwestern’s Medill School of Journalism. The

Bill would ban the reverse payment settlements that are keeping new generics off the market! Yesterday, a bill to ban the “pay-for-delay” settlements between brand-name drug companies and their generic competitors cleared its first legislative hurdle. T

Green mountain state strengthens disclosure law In the eleventh hour of its legislative session Friday night, Vermont passed a bill that would: -ban most gifts to physicians, -lift the trade secrets exemption in Vermont’s current gifts disclosure and tran

This week, Johnson and Johnson endorsed the Physician Payments Sunshine Act (S.301), making it the first major pharmaceutical company to endorse the legislation this year. The company also pledged to begin disclosing payments to physicians on its own pub

A new report out by the Institute of Medicine recommends that Congress pass a law like the Physician Payments Sunshine Act to disclose industry payments to doctors, and that continuing medical education for doctors be completely decoupled from industry fu

A Vermont federal district court gave good news to advocates of a VT law to ban the use of prescriber information for marketing by the drug industry. Our friends at the Prescription Project posted the following blog [available at http://blog.prescriptionp

Yesterday, the Vermont District Court upheld a 2007 law banning the use of prescriber-identifiable information to market prescription drugs. In his opinion, Judge J. Garvan Murtha affirmed the Vermont Legislature’s findings that the use of data-mining as

Attention: Consumers of doctor-administered drugs:  The court in the AWP litigation has extended the deadline to file consumer claims concerning these 200 prescription drugs (linked here) that were usually, but not always, administered in a doctor's offi